|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 24.79 EUR | +0.85% |
|
+2.74% | +6.67% |
| 02-04 | PHILIPS NV : Buy rating from Barclays | ZD |
| 02-03 | Preciseonco research consortium awarded EUR 14.9 million grant in precision cancer treatment | RE |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 3.38% | 3.37% | 31.18x | 1.89x | 1.63x | 9.77x | 13.87x | 27.85B | ||
| 0.31% | 0.34% | 30.39x | 3.91x | 5.25x | 20.75x | 23.03x | 204B | ||
| -.--% | -.--% | 55.25x | 7.89x | 14.3x | 33.4x | 38.31x | 173B | ||
| 0.58% | 0.61% | 41.55x | 3x | 6.79x | 22.01x | 24.14x | 153B | ||
| -.--% | -.--% | 37.41x | 4.58x | 6.07x | 19.81x | 21.67x | 113B | ||
| 2.56% | 2.92% | 20.22x | 2.4x | 2.36x | 11.67x | 15.11x | 54.57B | ||
| -.--% | -.--% | 34.77x | 4.28x | 6.99x | 23.13x | 25.31x | 45.68B | ||
| 0.9% | 0.99% | 25.66x | 5.8x | 6.82x | 17.52x | 18.78x | 39.57B | ||
| 0.19% | 0.22% | 16.82x | 2.92x | 1.9x | 10.28x | 11.92x | 36.76B | ||
| 0.79% | 0.84% | 24.3x | 4.69x | 5.1x | 17.76x | 19.36x | 36.65B | ||
| 2.76% | 3.15% | 23.93x | 5.86x | 6.12x | 17.36x | 19.44x | 33.03B | ||
| -.--% | -.--% | 33.95x | 8.84x | 7.4x | 20.44x | 24.24x | 22.7B | ||
| -.--% | -.--% | 25.14x | 7.63x | 4.53x | 16.53x | 19.87x | 18.29B | ||
| -.--% | -.--% | 21.96x | 2.86x | 3.83x | 11.81x | 12.7x | 16.7B | ||
| 1.59% | 1.7% | 22.97x | 2.66x | 2.08x | 10.42x | 15.96x | 13.22B | ||
| 0.28% | 0.28% | 40.05x | 1.56x | 4.77x | 15.9x | 17.51x | 11.52B | ||
| 0.42% | 0.53% | -77.65x | 2.54x | 2.29x | 14.45x | 17.76x | 6.37B | ||
| -.--% | -.--% | -73.25x | 4.73x | 71x | -125.38x | -100.62x | 6.21B | ||
| Average | 0.76% | 0.83% | 18.59x | 4.34x | 8.85x | 9.31x | 13.24x | 56.26B | |
| Weighted average by Cap. | 0.57% | 0.62% | 34.22x | 4.65x | 7.26x | 20.24x | 23.12x |
- Stock Market
- Equities
- PHIA Stock
- Sector Philips NV
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















